Intravenous injection administration suite

Abstract

The utility model relates to an intravenous injection administration kit. The intravenous administration kit comprises: a fluid container containing a drug and having a discharge port on a proximal end of the fluid container; a patient access tip having an access port on a distal end and a proximal end configured to be inserted into a patient; a tube having a distal end coupled to the discharge port of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and the patient access tip; and a light source that emits light along the tube toward the patient access tip.

Description

TECHNICAL FIELD

[0001] The present disclosure relates generally to an intravenous pump kit, and in some embodiments to an antimicrobial intravenous pump kit. SUMMARY

[0002] The disclosed subject matter relates to an antimicrobial intravenous administration kit. In certain embodiments, the intravenous administration kit includes a fluid container containing a medication and having a discharge outlet on a proximal end of the fluid container, a patient access tip having an access port on a distal end and a proximal end configured to be inserted into a patient, a tubing having a distal end coupled to the discharge outlet of the fluid container and a proximal end coupled to the distal end of the patient access tip, a pump coupled to the tubing between the fluid container and the patient access tip, and a light source emitting light along the tubing toward the patient access tip.

[0003] In certain embodiments, the light is emitted through the tubing. In certain embodiments, the light is transmitted via an optical fiber filament. In certain embodiments, the optical fiber filament includes polystyrene. In certain embodiments, the optical fiber filament extends from the pump to the patient access tip. In certain embodiments, the optical fiber filament extends partially from the pump to the patient access tip. In certain embodiments, the light is emitted via an optical connection. In certain embodiments, the light is transmitted via a tubing lumen. In certain embodiments, the light is transmitted through a tubing wall. In certain embodiments, the light source is disposed in the pump. In certain embodiments, the light travels in a proximal direction from the pump toward the patient access tip.

[0004] In certain embodiments, the light has antimicrobial properties. In certain embodiments, the light is indigo light. In certain embodiments, the indigo light has a wavelength of about 405 nm of the visible spectrum. In certain embodiments, the light source continuously emits the light. In certain embodiments, the fluid container and the patient access tip are in fluid communication through the tubing. In certain embodiments, the pump is coupled to the tubing closer to the fluid container than to the patient access tip.

[0005] In certain embodiments, the intravenous administration kit includes a fluid container containing a medication and having a discharge outlet on a proximal end of the fluid container, a patient access tip having an access port on a distal end and a proximal end configured to be inserted into a patient, a tubing having a distal end coupled to the discharge outlet of the fluid container and a proximal end coupled to the distal end of the patient access tip, a pump coupled to the tubing between the fluid container and the patient access tip, and a light source emitting light along the tubing toward the patient access tip, wherein the light is emitted through the tubing, and wherein the light has antimicrobial properties.

[0006] In certain embodiments, the light is transmitted via an optical fiber filament. In certain embodiments, the light is indigo light. BRIEF DESCRIPTION OF DRAWINGS

[0007] The foregoing summary, as well as the following detailed description of the application, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the application, there is shown in the drawings exemplary embodiments. It should be understood, however, that the application is not limited to the precise arrangements and instrumentalities shown.

[0008] In the drawings:

[0009] Figure 1 A patient is described receiving an infusion of a medical fluid using an IV pump.

[0010] Figure 2 is a side view of an IV set according to an exemplary embodiment of the present disclosure.

[0011] Figure 3 is a side view of an IV pump with optional windows according to an exemplary embodiment of the present disclosure.

[0012] Figure 4 is a top view of an IV set and patient access spike according to an exemplary embodiment of the present disclosure. DETAILED DESCRIPTION

[0013] The detailed description set forth below is intended as a description of various configurations of the subject technology and is not intended to represent the only configurations in which the subject technology can be practiced. The detailed description includes specific details for the purpose of providing a thorough understanding of the subject technology. However, it will be apparent to those skilled in the art that the subject technology can be practiced without these specific details. In some instances, well-known structures and components are shown in block diagram form in order to avoid obscuring the concepts of the subject technology. Like components are labeled with like numerals throughout the several views of the drawings. Reference numerals can be accompanied by a letter suffix to denote different instances of a common element, while common elements are generally referenced without a suffix.

[0014] While the description below refers to administration of medical fluids using peristaltic pumps of the present disclosure, it should be understood that the description is merely an example of use and does not limit the scope of the claims. Various aspects of the peristaltic pumps of the present disclosure can be used in any application requiring administration of a fluid flow.

[0015] Figure 1Patient 5 is depicted receiving an infusion of medical fluid using an IV pump 30. In the depicted example, IV pump 30 delivers medical fluid from a fluid container 36 to patient 5. Fluid container 36 is suspended at or above the patient's head and connected to an IV pump module 34 via an IV set 20, and subsequently to patient 5. In some embodiments, IV pump 30 includes a control unit 32 and a pumping module 34. Suitable IV pump configurations and systems are described, for example, in U.S. Patent Application No. 17 / 586,619, the entire disclosure of which is incorporated herein by reference.

[0016] The pumping module 34 may include a peristaltic pump to administer the medical fluid from the fluid container 36 to the patient 5. During operation of the peristaltic pump, it may be necessary to monitor the volume pumped by the peristaltic pump. As described in more detail below, in some applications, the peristaltic pump may include antimicrobial functionality.

[0017] like Figure 1 As shown, the IV set 20 includes a fluid container 36, a patient access tip 38, tubing 40, an IV pump 30, and a light source 42 ( Figure 2 ). Note that in the context of this disclosure, the terms "distal" and "proximal" are used with reference to a position relative to the patient 5. The fluid container 36 may contain a medical fluid (e.g., saline solution or liquid medication) for intravenous administration. The fluid container 36 may be rigid, such as Figure 1 As shown, or alternatively, it can be a flexible bag containing medical fluid. The fluid container 36 includes a discharge port 44 at its proximal end. The discharge port 44 can be a generally circular member extending through the proximal end of the fluid container 36. The discharge port 44 can have a septum (not shown) extending across it to prevent the medical fluid from passing therethrough. The discharge port 44 can have an inner surface or an outer surface that is configured to allow other components to be coupled thereto, as described in more detail below.

[0018] The tubing 40 may be made of plastic or rubber capable of conveying medical fluid therethrough. The tubing 40 may be sufficiently rigid to maintain a generally cylindrical shape when no external forces act upon it. However, the tubing 40 may be sufficiently flexible to bend and change its cross-section in response to forces acting upon it, such as by a pump as described in more detail below.

[0019] like Figure 2 As shown, the tubing 40 can have a distal end 40a and a proximal end 40b. The distal end of the tubing 40 can be configured to couple to the outlet 44. The distal end of the tubing 40 can include threads or protrusions that are received by corresponding threads or recesses of the outlet 44. Thus, the outlet 44 and the tubing 40 can be coupled by threads, a snap fit, adhesives, welding, or any other suitable form of coupling for a particular application.

[0020] The proximal end of the tubing 40 can be coupled to the distal end of the patient access spike 38. The patient access spike 38 can have an access port on its distal end. The distal end of the access spike 38 can include threads or protrusions that are received by corresponding threads or recesses of the tubing 40. In this way, the discharge port 44 and the tubing 40 can be coupled by threads, a snap fit, adhesive, welding, or any other suitable form of coupling for a particular application.

[0021] The patient access spike 38 has a proximal end that is configured to be inserted into the patient 5 during administration of the medical fluid. The proximal end can be a needle sized and shaped to deliver the medical fluid at a desired rate. The proximal end can be a 17 gauge needle, an 18 gauge needle, a 19 gauge needle, a 20 gauge needle, a 21 gauge needle, a 22 gauge needle, a 23 gauge needle, a 24 gauge needle, a 25 gauge needle, a 26 gauge needle, a 27 gauge needle, a 28 gauge needle, a 29 gauge needle, or a 30 gauge needle. In some embodiments, the fluid container 36 and the patient access spike 38 are in fluid communication through the tubing 40.

[0022] The IV pump 30 can be coupled to the tubing 40 between the fluid container 36 and the patient access spike 38. As Figure 1 shown, the IV pump 30 can be coupled to the tubing 40 closer to the fluid container 36 than to the patient access spike 38. The IV pump 30 can include internal components that engage the tubing 40 to manipulate the cross section, such that the flow of the medical fluid can be modulated and controlled according to the particular application of the IV set 20.

[0023] As Figure 2 shown, the light source 42 can emit light along the tubing 40 toward the patient access spike 38. In some embodiments, the light has antibacterial properties. For example, the light can kill pathogens. This can reduce bacterial colonization of the patient access site during administration of the medical fluid. The light can be indigo blue light. The indigo blue light can have a wavelength of the visible spectrum of at least 405 nm. In some embodiments, the indigo blue light has a wavelength of the visible spectrum of approximately 405 nm, 415 nm, 425 nm, 435 nm, 445 nm, or 450 nm. In some embodiments, the indigo blue light has a wavelength of the visible spectrum between 405 nm and 425 nm, 410 nm and 420 nm, 405 nm and 450 nm, 415 nm and 440 nm, and 425 nm and 430 nm. In some embodiments, the light source 42 emits light continuously. In some embodiments, the light source 42 emits light intermittently.

[0024] The application of light can reduce bacterial colonization without the need to introduce potentially harsh chemicals or other antimicrobial treatments, and can avoid the use of expensive silver or platinum-based materials that have natural disinfecting properties. This can increase catheter dwell time, allowing the IV set 20 to administer more medical fluid per use and reduce the number of insertions. Additionally, unlike other commonly used lights in this space (e.g., UV-based systems), indigo light is harmless to the human eye. A description of the use of indigo light proven effective against antimicrobial resistant organisms can be found at least in U.S. Patent No. 9,039,966, the entire contents of which are incorporated herein by reference.

[0025] Light can be emitted by a light source 42 through the tubing 40. In some embodiments, the light is transmitted via a fiber optic filament 46. The fiber optic filament 46 can be disposed within the tubing 40, affixed to the interior wall of the tubing 40, embedded in the wall of the tubing 40, or affixed to the exterior wall of the tubing 40, or any combination thereof. The fiber optic filament 46 can include a suitable material for transmitting light emitted from the light source 42, such as polystyrene. The fiber optic filament 46 can extend from the IV pump 30 to the patient access tip 38. In some embodiments, the fiber optic filament 46 extends partially from the IV pump 30 to the patient access tip 38. The fiber optic filament 46 can terminate at a depth where infection is most likely to occur, or at a depth that is most clinically advantageous where maximum catheter flexibility is balanced with antimicrobial efficacy.

[0026] like Figure 3 As shown, a light source 42 can be disposed in the IV pump 30. In some embodiments, light can be transmitted via an optical connector 48. The optical connector 48 can be disposed between the fluid container 36 and the patient access tip 38 and can transmit light toward the patient access tip. The optical connector 48 can include a body having an inlet 50 and an outlet 52. The inlet 50 can receive a proximal end of a first section of the tubing 40 and the outlet 52 can receive a distal end of a second section of the tubing 40 to allow medical fluid to flow therethrough. The optical connector can transmit light through the second portion of the tubing 40 (e.g., within or within an inner wall of the tubing 40) in any manner discussed above in conjunction with the fiber optic filament 46. In some embodiments, light can be transmitted via an optical lumen (not shown) extending along the tubing 40. In some embodiments, light can be transmitted through a wall of the tubing 40 (not shown).

[0027] For example, according to the various aspects described below, the subject technology is illustrated. For convenience, various examples of various aspects of the subject technology are described below. These are provided only as examples and do not limit the subject technology.

[0028] An intravenous administration set, the set comprising: a fluid container containing a medication and having a discharge outlet on a proximal end of the fluid container; a patient access tip having an entry port on a distal end and a proximal end configured to be inserted into a patient; a tubing having a distal end coupled to the discharge outlet of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and the patient access tip; and a light source emitting light along the tubing toward the patient access tip.

[0029] wherein the light is emitted through the tubing.

[0030] wherein the light is transmitted via an optical fiber filament.

[0031] wherein the optical fiber filament comprises polystyrene.

[0032] wherein the optical fiber filament extends from the pump to the patient access tip.

[0033] wherein the optical fiber filament extends partially from the pump to the patient access tip.

[0034] wherein the light is emitted via an optical connection.

[0035] wherein the light is transmitted via a tubing lumen.

[0036] wherein the light is transmitted through a tubing wall.

[0037] wherein the light source is disposed in the pump.

[0038] wherein the light travels in a proximal direction from the pump toward the patient access tip.

[0039] wherein the light has antibacterial properties.

[0040] wherein the light is indigo light.

[0041] wherein the indigo light has a wavelength of the visible spectrum of 405 nm.

[0042] wherein the light source emits light continuously.

[0043] wherein the fluid container and the patient access tip are in fluid communication through the tubing.

[0044] wherein the pump is coupled to the tubing closer to the fluid container than to the patient access tip.

[0045] An intravenous administration set, the set comprising: a fluid container containing a medication and having a discharge outlet on a proximal end thereof; a patient access tip having an entry port on a distal end and a proximal end configured to be inserted into a patient; a tubing having a distal end coupled to the discharge outlet of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and the patient access tip; and a light source emitting light along the tubing toward the patient access tip, wherein the light is emitted through the tubing, and wherein the light has antibacterial properties.

[0046] wherein the light is transmitted via an optical fiber filament.

[0047] wherein the light is indigo light.

[0048] In some embodiments, any one of the clauses herein can rely on any of the independent clauses or any of the dependent clauses. In one aspect, any of the clauses (e.g., dependent or independent clauses) can be combined with any other one or more clauses (e.g., dependent or independent clauses). In one aspect, a claim can include some or all of the language in a clause, sentence, phrase, or paragraph (e.g., steps, operations, means, or elements) recited in a clause. In one aspect, a claim can include some or all of the language recited in one or more clauses, sentences, phrases, or paragraphs. In one aspect, some of the language in each of the clauses, sentences, phrases, or paragraphs can be removed. In one aspect, additional language or elements can be added to the clauses, sentences, phrases, or paragraphs. In one aspect, the subject technology can be practiced without utilizing some of the components, elements, functions, or operations recited in the specification. In one aspect, the subject technology can be practiced with additional components, elements, functions, or operations.

[0049] The present disclosure is presented to enable a person having ordinary skill in the art to practice the various aspects described herein. The disclosure provides various examples of the subject technology, and the subject technology is not limited to these examples. Numerous modifications to these aspects will be readily apparent to those skilled in the art, and the general principles defined herein can be applied to other aspects.

[0050] Unless specifically stated otherwise, a reference to an element "wherever" can include "wherever" and "one or more of". Unless specifically stated otherwise, the term "some" refers to "one or more". The positive recitation of a word (e.g., he) includes the negative and neutral genders (e.g., she and it), and vice versa. The use of headings and subheadings (if any) is for convenience only and does not limit the disclosure.

[0051] The word "exemplary" is used herein to mean "serving as an example, instance, or illustration." Any aspect or design described herein as "exemplary" is not necessarily to be construed as preferred or advantageous over other aspects or designs. In one aspect, various alternative configurations and operations can be considered to be equivalent to what is described herein.

[0052] Phrases such as "aspect" do not imply that a particular aspect is essential, or that the aspects apply to all configurations of the subject technology. Disclosures related to one aspect can apply to all or one or more aspects. An aspect can provide one or more examples. Phrases such as "in one aspect" can refer to one or more aspects, and vice versa. Phrases such as "embodiment" do not imply that a particular embodiment is essential, or that the embodiments apply to all configurations of the subject technology. Disclosures related to one embodiment can apply to all or one or more embodiments. An embodiment can provide one or more examples. Phrases such as "in one embodiment" can refer to one or more embodiments, and vice versa. Phrases such as "configuration" do not imply that a particular configuration is essential, or that the configurations apply to all configurations of the subject technology. Disclosures related to one configuration can apply to all or one or more configurations. A configuration can provide one or more examples. Phrases such as "in one configuration" can refer to one or more configurations, and vice versa.

[0053] In one aspect, unless otherwise indicated, all measurements, values, ratings, positions, magnitudes, sizes, and other specifications that are set forth in this specification, including in the claims that follow, are approximate, not exact. In one aspect, they are intended to have a reasonable range commensurate with the functions to which they relate and with ordinary

[0054] In one aspect, the term "coupled" and the like can mean directly coupled. In another aspect, the term "coupled" and the like can mean indirectly coupled.

[0055] Terms such as "top," "bottom," "front," "back," and the like as used in this disclosure should be understood as referring to an arbitrary frame of reference, not necessarily a normal gravity reference frame. Thus, top surfaces, bottom surfaces, front surfaces, and back surfaces can extend upward, downward, diagonally, or horizontally in a gravity reference frame.

[0056] Various items can be rearranged without departing from the scope of the subject technology, for example, they can be re-ordered, or divided into different ways. All structural and functional equivalents to the elements of the various aspects described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the claims. Moreover, nothing that has been stated or described is intended to cause a withdrawal of the public dedication of any patent application fields, even if such disclosure is made in the claims. Under the provisions of 35 U.S.C. § 1 12, paragraph six, the claim element for which the phrase "means for" has been transposed is necessarily present at the end of the claim where required as a sentence ending. Moreover, for any claim in which the word "means" is used in the claim, the claim does not cover or render inoperative any patentable device, solely because of the use of the word "means" in the claim. In addition, the scope of the terms "comprise," "have" and the like are meant not to be limiting but to allow for variations of what is described in the specification and claims. This summary of the application has been provided to introduce some concepts of the application and not to limit the scope of the application.

[0057] The title, background, brief summary, abstract, and drawings of the disclosure are hereby incorporated into the disclosure and provided as illustrative examples of the disclosure, not limiting descriptions. This application is filed based on the understanding that they will not be used to limit the scope or meaning of the claims. In addition, in the DETAILED DESCRIPTION, it can be seen that the description provides illustrative examples, and for simplicity of the disclosure, various features are combined in various embodiments. The disclosed method should not be interpreted as reflecting an intent that the claimed subject matter require more features than are expressly recited in each claim. Instead, as reflected in the appended claims, the utility subject matter is in less than all features of a single disclosed construction or operation. The appended claims are therefore incorporated into the detailed description, each claim independently as a separately claimed subject matter. The claims are not intended to be limited to the aspects described herein, but are to be accorded the full scope consistent with the language claims, and include all legal equivalents. Nonetheless, no claim is intended to embrace subject matter that fails to satisfy the requirements of 35 U.S.C. §§ 101, 102, or 103, nor should such claims be interpreted in such a manner.

Claims

1. An intravenous injection administration set, characterized in that, It comprises: a fluid container containing a medicament and having a discharge outlet on a proximal end of the fluid container; a patient access tip having an entry port on a distal end and a proximal end configured to be inserted into a patient; a tubing having a distal end coupled to the discharge outlet of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and patient access tip; and a light source emitting light along the tubing toward the patient access tip. The light is emitted through the tubing.

2. The intravenous administration set of claim 1, wherein, The light is transmitted via an optical fiber filament.

3. The intravenous administration set of claim 2, wherein, The optical fiber filament extends from the pump to the patient access tip.

4. The intravenous administration set of claim 3, wherein, The optical fiber filament extends partially from the pump to the patient access tip.

5. The intravenous administration set of claim 3, wherein, The light is emitted via an optical connection.

6. The intravenous administration set of claim 2, wherein, The light is transmitted via a tubing lumen.

7. The intravenous administration set of claim 2, wherein, The light is transmitted through a tubing wall.

8. The intravenous administration set of claim 2, wherein, The light source is disposed in the pump.

9. The intravenous administration set of claim 1, wherein, The light travels in a proximal direction from the pump toward the patient access tip.

10. The intravenous administration set of claim 9, wherein, The light has an antibacterial property.

11. The intravenous administration set of claim 1, wherein, The light is indigo light.

12. The intravenous administration set of claim 11, wherein, The indigo light has a wavelength of the visible spectrum of 405 nm.

13. The intravenous administration set of claim 12, wherein, The light source continuously emits light.

14. The intravenous administration set of claim 1, wherein, The fluid container and patient access tip are in fluid communication through the tubing.

15. The intravenous administration set of claim 1, wherein, The pump is coupled to the tubing closer to the fluid container than to the patient access tip.

16. The intravenous administration set of claim 1, wherein, It comprises:

17. An intravenous injection administration set, characterized in that, a fluid container containing a medicament and having a discharge outlet on a proximal end of the fluid container; a patient access tip having an entry port on a distal end and a proximal end configured to be inserted into a patient; a tubing having a distal end coupled to the discharge outlet of the fluid container and a proximal end coupled to the distal end of the patient access tip; a pump coupled to the tubing between the fluid container and patient access tip; and a light source emitting light along the tubing toward the patient access tip, wherein the light is emitted through the tubing, and wherein the light has an antibacterial property. The light is transmitted via an optical fiber filament. The light is indigo light.

18. The intravenous administration set of claim 17, wherein, ​ 19. The intravenous administration set of claim 17, wherein, ​

Images